Many of us have just assumed that RAC will be sold to BP from phase 2 onwards.
But perhaps not. Looking at this add & the other ongoing programs that we have not been informed of progress.....
Maybe RAC could instead become an incubator for promising molecules and Bisantrene be the first to be sold or licensed, giving the firm revenue for ongoing development & large divvies for shareholders... I'd be happy with that too !
General Comments / Chat, page-10411
-
-
- There are more pages in this discussion • 818 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.65 |
Change
0.040(2.49%) |
Mkt cap ! $279.4M |
Open | High | Low | Value | Volume |
$1.61 | $1.66 | $1.61 | $65.44K | 39.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5636 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 1973 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1500 | 1.640 |
4 | 10335 | 1.635 |
2 | 2950 | 1.630 |
2 | 2388 | 1.625 |
2 | 5994 | 1.620 |
Price($) | Vol. | No. |
---|---|---|
1.655 | 1973 | 2 |
1.660 | 5000 | 1 |
1.665 | 3884 | 3 |
1.670 | 332 | 1 |
1.680 | 1222 | 1 |
Last trade - 10.58am 29/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |